Table 2.
Real-time PCR (qPCR) Data
| Treatment | 50 μg/ml AGP | 500 μg/ml AGP | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Target Gene | 3 hrs | 6 hrs | 12 hrs | 24 hrs | 48 hrs | 3 hrs | 6 hrs | 12 hrs | 24 hrs | 48 hrs |
| Cytokines | ||||||||||
| IL-10 | 1.17 ± 0.1 | 1.34 ± 0.3 | 0.72 ± 0.1 | 1.03 ± 0.2 | 0.97 ± 0.0 | 0.47 ± 0.0 | 1.68 § ± 0.0 | 1.89 † ± 0.2 | 1.02 ± 0.1 | 0.49 * ± 0.1 |
| TNF-α | 0.25 ± 0.1 | 1.99 † ± 0.1 | 1.22 ± 0.2 | 0.74 ± 0.1 | 1.18 ± 0.3 | 0.40 ± 0.0 | 1.71 § ± 0.1 | 1.69 § ± 0.1 | 0.97 ± 0.3 | 0.97 ± 0.0 |
| IL-1β | 0.84 ± 0.1 | 3.42 § ± 1.1 | 0.93 ± 0.1 | 0.29 ± 0.1 | 2.02 ± 0.6 | 2.27 ±0.9 | 1.81 ± 0.7 | 12.36 † ± 0.4 | 4.55 † ± 0.3 | 1.46 ± 0.2 |
| IL-6 | 0.96 ± 0.0 | 2.46 ± 0.1 | 3.06 ± 0.1 | 2.45 ± 0.5 | 2.63 ± 0.4 | 1.49 ±0.6 | 30.45 † ± 4.4 | 8.56 § ± 1.0 | 26.32 † ± 2.9 | 20.09 § ± 3.7 |
| TJ Proteins | ||||||||||
| Occludin | 1.43 ± 0.4 | 0.90 ± 0.0 | 1.60 § ± 0.2 | 1.01 ± 0.2 | 0.64 ± 0.2 | 0.66 ± 0.1 | 0.82 ± 0.1 | 0.58 * ± 0.1 | 0.47 † ± 0.2 | 0.36 † ± 0.1 |
| ZO-1 | 2.19* ±0.7 | 0.66 * ± 0.1 | 1.22 ± 0.1 | 0.75 ± 0.2 | 0.73 ± 0.1 | 3.4 § ± 0.9 | 0.97 ± 0.1 | 0.90 ± 0.2 | 0.38 † ± 0.1 | 0.39 † ± 0.1 |
| Claudin-2 | 1.45 ± 0.1 | 0.48 † ± 0.2 | 1.08 ± 0.1 | 0.24 † ± 0.1 | 0.29 † ± 0.0 | 0.73 ± 0.0 | 0.76 ± 0.1 | 1.09 ± 0.0 | 0.48 † ± 0.0 | 0.22 † ± 0.0 |
| Claudin-5 | 1.20 ± 0.1 | 1.01 ± 0.1 | 1.34 ± 0.4 | 1.89 ± 0.4 | 5.87 † ± 0.7 | 0.54 ± 0.1 | 1.36 ± 0.1 | 0.54 * ± 0.1 | 0.85 ± 0.2 | 2.42 § ± 0.3 |
| JAM-1 | 1.08 ± 0.2 | 0.64 ± 0.1 | 1.60 ± 0.2 | 0.28 † ± 0.1 | 0.38 § ± 0.2 | 0.65 ± 0.3 | 0.45 § ± 0.1 | 1.44 * ± 0.2 | 0.47 § ± 0.1 | 0.32 † ± 0.1 |
Results have been calculated using the Pfaffl method to produce a ratio (treatment: control) that represents mean ± SEM for the effect of the treatment on mRNA expression for the respective target gene with GAPDH as the reference gene.
indicates p-value <0.05;
indicates p-value <0.01;
indicates p-value <0.001, compared with respective control; ratio means larger than two or less than 0.5 are bolded; n= 3–6.